Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prefibrotic versus overtly fibrotic primary myelofibrosis: clinical, cytogenetic, molecular and prognostic comparisons

5 Jul 2017

Abstract excerpt

The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Chronic Myeloid Leukemia Treatments
Share to Myeloproliferative Neoplasms: Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28677834
DOI: 10.1111/bjh.14838

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prefibrotic versus overtly fibrotic primary myelofibrosis: clinical, cytogenetic, molecular and prognostic comparisonsPMID 28677834Read ↗

Evidence that prefibrotic myelofibrosis is aligned along a clinical and biological continuum featuring primary myelofibrosis.Semantic proximity Read ↗

Differential prognostic impact of cytopenic phenotype in prefibrotic vs overt primary myelofibrosis.Semantic proximity Read ↗

Myelofibrosis biology and contemporary management.Semantic proximity Read ↗

Presentation and outcome of patients with 2016 WHO diagnosis of prefibrotic and overt primary myelofibrosis.Semantic proximity Read ↗

Pre-fibrotic/early primary myelofibrosis vs. WHO-defined essential thrombocythemia: The impact of minor clinical diagnostic criteria on the outcome of the disease.Semantic proximity Read ↗

A provider's guide to primary myelofibrosis: pathophysiology, diagnosis, and management.Semantic proximity Read ↗

Essential thrombocythemia vs. early/prefibrotic myelofibrosis: why does it matter.Semantic proximity Read ↗

Thrombocytosis Phenotype in Prefibrotic Primary Myelofibrosis: Risk Stratification and Prognostic Significance.Semantic proximity Read ↗

U2AF1 mutation types in primary myelofibrosis: phenotypic and prognostic distinctions.Semantic proximity Read ↗

Biological drivers of clinical phenotype in myelofibrosis.Semantic proximity Read ↗

Epidemiology and disease characteristics of myelofibrosis: a comparative analysis between Italy and global perspectivesSemantic proximity Read ↗

How I Diagnose Primary Myelofibrosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.